The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

Gilead's once-yearly injectable lenacapavir shows promising results in HIV prevention, with a 96% reduction in infections and plans for regulatory filings by 2027.

Musk has argued in favor of regulating AI. But venture capitalists like Andreessen, who founded Andreessen Horowitz, a VC ...

A post on Facebook claims that a new cure for Acquired immunodeficiency syndrome (AIDS) has been discovered and will cost $40 ...

The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...

The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...

Dr. Greg Shay is a pediatric pulmonologist, a children's lung specialist, with the NGO MedGlobal who has just returned from a ...

Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.

The incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir compared with daily oral emtricitabine-tenofovir disoproxil fumarate.